BMP6-induced modulation of the tumor micro-milieu.


Journal

Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562

Informations de publication

Date de publication:
01 2019
Historique:
received: 09 11 2017
accepted: 27 07 2018
revised: 22 06 2018
pubmed: 2 9 2018
medline: 27 2 2019
entrez: 2 9 2018
Statut: ppublish

Résumé

Melanoma is the deadliest form of skin cancer with rising incidence, creating a significant health problem. We discovered increased expression of bone morphogenetic protein 6 (BMP6) in melanoma cells and tissues, and observed that BMP6 deficiency caused significantly delayed tumor onset and decelerated tumor progression in a melanoma mouse model. Moreover, we determined that BMP6 inhibits dermal mast cell recruitment and found that mast cell-derived mediators significantly reduced melanoma growth in vitro. In line with this, mast cell deficiency accelerated tumor onset and progression in a melanoma mouse model. Analysis of human melanoma tissues revealed a strong negative correlation between melanoma proliferation and mast cell infiltration. This study elucidates a novel role of BMP6-induced modulation of the tumor microenvironment.

Identifiants

pubmed: 30171260
doi: 10.1038/s41388-018-0475-x
pii: 10.1038/s41388-018-0475-x
doi:

Substances chimiques

BMP6 protein, human 0
Bmp6 protein, mouse 0
Bone Morphogenetic Protein 6 0
Neoplasm Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

609-621

Références

Immunity. 2011 Nov 23;35(5):832-44
pubmed: 22101159
Lab Invest. 2008 Aug;88(8):842-55
pubmed: 18560367
J Immunol. 1991 Oct 1;147(7):2253-8
pubmed: 1918961
Oncotarget. 2016 Sep 20;7(38):62292-62304
pubmed: 27556702
Gastroenterology. 2010 Jan;138(1):372-82
pubmed: 19786029
J Ethnopharmacol. 2014 Sep 11;155(2):1118-24
pubmed: 24969825
Semin Oncol. 2002 Jun;29(3 Suppl 7):35-40
pubmed: 12068387
Exp Dermatol. 2011 May;20(5):435-40
pubmed: 21496114
J Immunol. 2009 Sep 1;183(5):3014-22
pubmed: 19667094
Gut. 2015 Jun;64(6):973-81
pubmed: 25011936
Eur J Cancer. 2008 Nov;44(16):2526-34
pubmed: 18774289
Cell Signal. 2011 Apr;23(4):609-20
pubmed: 20959140
Cancer Sci. 2009 Nov;100(11):2218-25
pubmed: 19735263
Oncol Rep. 2016 Mar;35(3):1823-30
pubmed: 26751737
J Invest Dermatol. 2003 Jan;120(1):36-47
pubmed: 12535196
Nat Genet. 2009 Apr;41(4):478-81
pubmed: 19252488
Exp Eye Res. 2014 Oct;127:59-68
pubmed: 25051141
Cancer Metastasis Rev. 2011 Mar;30(1):45-60
pubmed: 21287360
Cell Signal. 2006 Aug;18(8):1279-86
pubmed: 16305822
Nat Genet. 2009 Apr;41(4):482-7
pubmed: 19252486
Int J Cancer. 2011 Sep 1;129(5):1064-74
pubmed: 21077158
Cold Spring Harb Perspect Biol. 2016 Jun 01;8(6):
pubmed: 27252362
Melanoma Res. 2015 Dec;25(6):479-85
pubmed: 26317168
J Invest Dermatol. 1991 Feb;96(2):180-5
pubmed: 1899443
Genes Dev. 1989 Nov;3(11):1657-68
pubmed: 2481605
J Biochem. 2010 Jan;147(1):35-51
pubmed: 19762341
Mod Pathol. 2006 Jan;19(1):149-59
pubmed: 16258517
Nat Genet. 2003 May;34(1):108-12
pubmed: 12704387
Br J Cancer. 2013 Dec 10;109(12):3116-24
pubmed: 24169347
Exp Dermatol. 2012 Oct;21(10):786-8
pubmed: 22882420
Cell Mol Life Sci. 2010 Oct;67(20):3535-48
pubmed: 20480203
Trends Immunol. 2004 May;25(5):235-41
pubmed: 15099563
Pigment Cell Melanoma Res. 2010 Feb;23(1):103-11
pubmed: 19843246
Nat Protoc. 2006;1(5):2315-9
pubmed: 17406473
Int J Dermatol. 2014 Jul;53(7):806-11
pubmed: 23621615
Cell Death Differ. 2016 May;23(5):912
pubmed: 26915292
J Cell Biol. 1993 Mar;120(5):1281-8
pubmed: 8436594
Carcinogenesis. 2011 Aug;32(8):1176-82
pubmed: 21642354
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5528-32
pubmed: 7515504
Cancer Res. 2005 Jan 15;65(2):448-56
pubmed: 15695386
Nat Med. 2011 Jan;17(1):87-95
pubmed: 21170045
Dev Genet. 1998;22(4):321-39
pubmed: 9664685
Oncotarget. 2017 Jun 16;8(43):75675-75686
pubmed: 29088901
Cancer Res. 2007 Mar 1;67(5):2298-305
pubmed: 17332361
Pharmacol Res. 2017 Sep;123:95-102
pubmed: 28690075
J Cell Biol. 1993 Jan;120(2):493-502
pubmed: 8421061
Pol J Pathol. 2011 Sep;62(3):139-44
pubmed: 22102069
Allergy. 2008 Oct;63(10):1255-66
pubmed: 18671772
Clin Sci (Lond). 2011 Jun;120(11):473-84
pubmed: 21320076

Auteurs

David Stieglitz (D)

Institute of Biochemistry, Emil Fischer Center, Department of Biochemistry and Molecular Medicine, University of Erlangen-Nürnberg, Erlangen, Germany.

Susanne Lamm (S)

Institute of Biochemistry, Emil Fischer Center, Department of Biochemistry and Molecular Medicine, University of Erlangen-Nürnberg, Erlangen, Germany.

Simone Braig (S)

Department of Pharmacy, Pharmaceutical Biology, University of Munich, Munich, Germany.

Lena Feuerer (L)

Institute of Biochemistry, Emil Fischer Center, Department of Biochemistry and Molecular Medicine, University of Erlangen-Nürnberg, Erlangen, Germany.

Silke Kuphal (S)

Institute of Biochemistry, Emil Fischer Center, Department of Biochemistry and Molecular Medicine, University of Erlangen-Nürnberg, Erlangen, Germany.

Peter Dietrich (P)

Institute of Biochemistry, Emil Fischer Center, Department of Biochemistry and Molecular Medicine, University of Erlangen-Nürnberg, Erlangen, Germany.

Stephanie Arndt (S)

Department of Dermatology, University Medical Center Regensburg, Regensburg, Germany.

Bernd Echtenacher (B)

Regensburg Center for Interventional Immunology (RCI) and University Medical Center of Regensburg, Regensburg, Germany.

Claus Hellerbrand (C)

Institute of Biochemistry, Emil Fischer Center, Department of Biochemistry and Molecular Medicine, University of Erlangen-Nürnberg, Erlangen, Germany.
Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen, Germany.

Sigrid Karrer (S)

Department of Dermatology, University Medical Center Regensburg, Regensburg, Germany.

Anja-Katrin Bosserhoff (AK)

Institute of Biochemistry, Emil Fischer Center, Department of Biochemistry and Molecular Medicine, University of Erlangen-Nürnberg, Erlangen, Germany. Anja.Bosserhoff@fau.de.
Comprehensive Cancer Center (CCC) Erlangen-EMN, Erlangen, Germany. Anja.Bosserhoff@fau.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH